The PASA Consortium currently has six studies under development.
The following studies are under development. Use the links in the box on the left for information on each of the studies under development by the PASA Consortium.
AS140026-A3a
Dewleen Baker, M.D. and Victoria Risbrough, Ph.D.
Study Type: Phase II Clinical Proof of Concept Trial
Protocol: Efficacy and Safety Study of PT150 (formerly ORG 34517) in Veterans with Comorbid PTSD and AUD
Participating Site: VA San Diego Health Care System (VASDHS)
AS140026-A3c
Christopher Verrico, Ph.D.
Study Type: Phase I Pharmacokinetic Study
Protocol: Effects of Ethanol (EtOH) on the Pharmacokinetics of PT-150 (Formerly ORG34517)
Participating Site: Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)
AS140026-A6
Christopher Verrico, Ph.D.
Study Type: Phase II Clinical Trial
Protocol: Lofexidine Combined with Buprenorphine for Reducing Symptoms of Post-Traumatic Stress Disorder and Opioid Use Relapse in Veterans
Participating Site: Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC)
Study Type: Phase II Clinical Trial
Protocol: N-acetylcysteine Treatment to Reduce Alcohol Use, Cognitive Impairment and PTSD Symptom Severity in Veterans with Traumatic Brain Injury and Alcohol Use Disorder: A Confirmatory Study
Participating Site: TBA
AS170014-A1
Colin N Haile, M.D., Ph.D.
Study Type: Preclinical Trial
Protocol: Novel Strategies for the Treatment of Opioid Use Disorder and Post-Traumatic Stress Disorder: Anti-Fentanyl Vaccine and Buprenorphine Combination Therapy
Participating Site: Baylor College of Medicine (BCM)
AS170014-A2
Michael T. Bardo, Ph.D.
Study Type: Preclinical Trial
Protocol: Preclinical assessment of PT-150 for opioid use disorder and PTSD
Participating Site: University of Kentucky